Anti-counterfeit Pharmaceutical Packaging Market - Growth, Demand and Key Players to 2026

Anti-counterfeit pharmaceutical packaging has comparatively high demand, attributed to increasing demand for safe packaging to combat the illicit drug market. The Mass Encoding Technology segment is estimated to account for a market share of 32.2% in the global anti-counterfeit pharmaceutical packaging market by 2016 end and is expected to witness a further rise of 40 basis points to account for 32.4% by 2026.

Owing to an astonishing CAGR of 13.1%, coupled with the current market share of over 40%, the Track and Trace Technologies segment is projected to be the most attractive segment in the global anti-counterfeit pharmaceutical packaging market over the forecast period.

Get an exclusive sample of this report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-2385

A slew of restrictive measures to combat the rise of counterfeit medicines is cementing the growth of the global anti-counterfeit pharmaceuticals packaging market

Counterfeit medicines are fake medicines. These may be contaminated or contain wrong ingredients. It is estimated that globally, around 10% - 15% of medicines are counterfeit. This poses a threat to the global pharmaceuticals market. Counterfeit pharmaceutical products affect both, i.e. patients as well as pharma companies with their brand reputation. The rampant counterfeiting of drugs has pushed pharma producers to opt for secure solutions. Anti-counterfeiting packaging is one of the measures that pharma majors are relying on. Pharmaceutical companies have been incorporating anti-counterfeit solutions with their product packages; of these, hologram, bar code, and water is common and considered as a conventional option for the same. However, with advancement in technology, pharmaceutical manufacturers are also integrating new and innovative options with conventional solutions such as integrating authentication overt features with covert elements, forensics, and track & trace elements. These measures have translated into fruitful results for pharmaceutical companies and tier II pharma companies also prefer similar approaches. These effective measures considered by pharma companies resulted in the sudden increase in demand for anti-counterfeit pharmaceutical packaging across the globe.

Obtain Report Details @
https://www.futuremarketinsights.com/reports/anti-counterfeit-pharmaceutical-packaging-market

Track & Trace Technologies segment will be a game changer in the anti-counterfeit pharmaceutical packaging market

Anti-counterfeit pharmaceutical packaging market is segmented on the basis of usage feature as convert features, divert features, forensic markers, tamper evidence and track & trace technologies [sterilisation and identification system]. The track & trace technologies segment is predicted to accumulate US$ 2,742.5 Mn by 2026, registering a substantially surging CAGR of 13.1% over the forecast period with a relatively high value share of more than 40% by 2026. The covert feature segment of the global anti-counterfeit pharmaceutical packaging market was valued at US$ 249.1 Mn in 2015 and is projected to reach a market value of US$ 871.8 Mn by 2026, registering a CAGR of 12.3% during the forecast period. The segment is expected to create incremental $ opportunity of US$ 599.7 Mn between 2016 and 2026.

Smart technologies to push the anti-counterfeit pharmaceutical packaging market ahead during the forecast period

Anti-counterfeit pharmaceutical packaging is segmented on the basis of technology as RFID [active tags, passive tags, semi-active tags], security inks and coatings, security printing and graphics, hologram, mass encoding [Barcode Application, Digital Mass Serialization, Digital Mass Encryption] and others [Electromagnetic, Surveillance Technologies]. The RFID technology segment of the global anti-counterfeit pharmaceutical packaging market was valued at US$ 331.8 Mn in 2015 and is projected to reach a market value of US$ 1,146.8 Mn by 2026, registering a CAGR of 12.3% during the forecast period. The segment is expected to create incremental $ opportunity of US$ 786.8 Mn between 2016 and 2026.

About FMI

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact FMI

3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom

T: + 44 (0) 20 7692 8790
D: +44 (0) 20 3287 4268
Email:sales@futuremarketinsights.com

This release was published on openPR.